• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

Nofetumomab Product Approval Information - Licensing Action

Proper name: Nofetumomab
Tradename: Verluma
Manufacturer: Dr. Karl Thomae GmbH, 88397 Biberach/Riss, Germany, License #1199
Indication for Use: Detection of extensive stage disease in patients with biopsy-confirmed, previously untreated, small cell lung cancer
Approval Date: 8/20/96
Type of submission: Biologics license application

 


Approval Letter (PDF)

Label (PDF)

Reviews (PDF)
    Clinical (40 pages)
    Stability (2 pages)
    Statistical (25 pages)